Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-κB-NLRP3 Inflammasome Signaling Pathway-Reference-Cited by-同舟云学术

Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-κB-NLRP3 Inflammasome Signaling Pathway

Published:2022-08-30 Issue:5 Volume:200 Page:561-572
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Aydin Pelin,Magden Zeynep Berna Aksakalli^ORCID,Uzuncakmak Sevgi Karabulut^ORCID,Halici Hamza^ORCID,Akgun Nurullah^ORCID,Mendil Ali Sefa^ORCID,Mokhtare Behzad^ORCID,Cadirci Elif^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00408-022-00564-9.pdf

Reference50 articles.

1. Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526–2533. https://doi.org/10.1001/jama.2012.5669

2. Ashbaugh D, Boyd Bigelow D, Petty T, Levine B (1967) Acute respiratory distress in adults. Lancet 290:319–323. https://doi.org/10.1016/S0140-6736(67)90168-7

3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M et al (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–1693. https://doi.org/10.1056/NEJMoa050333

4. Goss CH, Brower RG, Hudson LD, Rubenfeld GD (2003) Incidence of acute lung injury in the United States. Crit Care Med 31:1607–1611. https://doi.org/10.1097/01.CCM.0000063475.65751.1D

5. Torbic H, Krishnan S, Harnegie MP, Duggal A (2021) Neuromuscular blocking agents for ARDS: a systematic review and meta-analysis. Respir Care 66:120–128. https://doi.org/10.4187/respcare.07849

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions;Expert Opinion on Investigational Drugs;2024-08-11

2. Targeting Aquaporin-5 by Phosphodiesterase 4 Inhibition Offers New Therapeutic Opportunities for Ovarian Ischemia Reperfusion Injury in Rats;Reproductive Sciences;2024-03-07

3. Effects of Nintedanib on the Lungs via NLRP3 in a Model of Lipopolysaccharide-induced Acute Lung Injury in Rats;Namık Kemal Tıp Dergisi;2024-03-01

4. Fortunellin ameliorates LPS‐induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF‐κB/NLRP3 pathway;Immunity, Inflammation and Disease;2024-03

5. Procyanidin B1 Protects HPAEpiCs from Lipopolysaccharide-mediated Inflammation Damage by Modulating the eNOS/NO/cGMP Pathway;J BIOL REG HOMEOS AG;2024